Louis Md Brenner - May 10, 2021 Form 4 Insider Report for Allena Pharmaceuticals, Inc. (ALNAQ)

Signature
/s/ Kevin Brennan, attorney-in-fact
Stock symbol
ALNAQ
Transactions as of
May 10, 2021
Transactions value $
-$27,989
Form type
4
Date filed
5/12/2021, 04:45 PM
Next filing
Nov 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNAQ Common Stock Sale -$28K -25.2K -11.03% $1.11* 203K May 10, 2021 Direct F1
transaction ALNAQ Common Stock Options Exercise +83.7K +57.81% 229K May 10, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNAQ Restricted Stock Units Options Exercise $0 -83.7K -40% $0.00 126K May 10, 2021 Common Stock 83.7K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected by the Reporting Person and represents shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.
F3 40% shall vest on May 10, 2021 and the remaining 60% shall vest on November 10, 2021, subject to the Reporting Person's continued service through each vesting date.